Patient Leaflet Updated 14-Sep-2023 | Bristol Myers Squibb Pharmaceuticals limited
Kenalog Intra-Articular/Intramuscular Injection
KENALOG™
INTRA-ARTICULAR / INTRAMUSCULAR INJECTION 40 mg/ml
Triamcinolone Acetonide
1. What Kenalog IA/IM Injection is and what it is used for
2. What you need to know before you are given Kenalog IA/IM Injection
3. Receiving Kenalog IA/IM Injection
4. Possible side effects
5. How to store Kenalog IA/IM Injection
6. Content of the pack and other information
The name of this medicine is Kenalog IA/IM Injection. Each injection contains triamcinolone acetonide 40 mg/ml as the active ingredient. Triamcinolone acetonide belongs to a group of medicine called corticosteroids (steroids).
Kenalog IA/IM Injection is for the treatment of joint pain, swelling and stiffness in inflammatory disorders such as rheumatoid arthritis.
It is also for the treatment of various allergic disorders including asthma, blood disorders, hormone problems, rheumatic fever, and problems associated with digestive system, kidneys, lungs or skin.
Kenalog IA/IM Injection is not recommended for children under 6 years.
Contact your doctor if you experience blurred vision or other visual disturbances.
If any of these applies to you, talk to a doctor before taking Kenalog IA/IM Injection.
Steroid medicines suppress your body's natural immune response. Therefore, if you come into contact with anyone who has an infectious disease such as chickenpox, shingles or measles, consult your doctor as soon as possible.
While you are being treated with this medicine (or if you have recently stopped a course of treatment) do not have any vaccination without consulting your doctor.
You must take care not to over-use a joint which feels better after you receive Kenalog IA/IM injection. The joint will still need to recover from the inflammation which caused your symptoms.
Please tell your doctor if you are taking, or have recently taken any other medicines, including medicines obtained without a prescription.
Some medicines may increase the effects of Adcortyl and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).
This is especially important if you are taking;
or medicines to treat;
If you are taking any of these medicines, or are not sure, please consult your doctor.
Before surgery and anaesthesia (even at the dentist) you should tell the doctor or dentist that you are being treated with Kenalog IA/IM injection.
If you are pregnant, planning to become pregnant, or if you are breast-feeding you should make sure you discuss this with your doctor as soon as possible before receiving Kenalog IA/IM injection.
This medicine does not usually affect your ability to drive or operate machinery but it can affect your eyesight. Tell your doctor immediately if you have any pain in the eyes, problems with your vision.
Your doctor or pharmacist will have given you a ‘Steroid Treatment Card’ and, if required also a ‘Steroid Emergency Card’ with your prescription or medicine.
YOU SHOULD ALWAYS CARRY THESE CARDS WITH YOU as they must be shown to any of the following persons:
Doctor or Nurse - before having any surgery or emergency treatment or if any new treatment is prescribed.
Dentist - before having any dental surgery
Pharmacist - before buying any medicine
Optician - it is advisable to have regular eye tests
Kenalog IA/IM Injection contains 15 mg/ml benzyl alcohol which may cause harmful or allergic reactions in infants and children. Kenalog IA/IM injection must not be given to premature or newly born babies
The effect of the injection will vary from patient to patient and further injections may be given to you when symptoms return and not at regular intervals.
The usual doses are;
Use in inflammatory joint disorders:
The dose of injection into a joint or tendon sheath depends upon the size of the joint to be treated and the severity of the condition which is being treated. Doses of 5-10 mg (0.125-0.25 ml) for smaller joints and up to 40 mg (1.0 ml) for larger joints usually give relief of symptoms.
This medicine should not be used for injection into the Achilles tendon.
Use in allergic disorders:
The usual starting dose is 40 mg (1.0 ml) injected deeply into the upper outer area of the buttock. If you require a further injection, this should be made into the same area on the other buttock. Some patients with pollen asthma find that one injection of 40-100 mg improves asthmatic symptoms.
Your doctor will advise you whether it is wise for you to have further injections.
Deep intramuscular injection must be given into the large muscles of the buttock and not into the upper arm or the thigh.
This medicine should not be given into a vein.
If you are receiving long-term intramuscular treatment with Kenalog IA/IM injection your doctor may advise you to eat more protein. This should help to reduce the gradual loss of weight that can sometimes occur with long-term treatment.
Treatment with steroids is usually kept as short as possible and must not be stopped abruptly. Joints may become permanently damaged by repeated injections over a long period of time.
When the treatment is stopped you may notice flu-like symptoms, runny nose or itchy eyes or skin.
During times of illness or stress, patients on long-term treatment may require the addition of oral steroid tablets, or, if they have recently finished a course of Kenalog IA/IM injections, may need to start taking oral steroid tablets for a while.
Mental health problems while taking Kenalog IA/IM injection
Mental health problems can happen while taking steroids like Kenalog IA/IM Injection (see also section 4 Possible Side Effects).
Talk to a doctor if you (or someone taking this medicine), shows any signs of mental health problems. This is particularly important if you are depressed, or might be thinking about suicide. In a few cases, mental health problems have happened when doses are being lowered or stopped.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Steroids including Kenalog IA/IM injection can cause serious mental health problems. These are uncommon in both adults and children.
If you notice any of the following side effects talk to a doctor straight away.
Serious cases of anaphylactic reactions (i.e. a serious allergic reaction) and anaphylactic shock including death have been reported. If you notice any of the following, contact your doctor immediately:
As these may be signs of an allergic reaction
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Not known: frequency cannot be estimated from available data
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Kenalog IA/IM injection will be kept in the pharmacy until it is given to you by your doctor or nurse.
It should not be used after the expiry date shown on the outer packaging.
It should not be stored above 25°C nor should it be allowed to freeze.
The container should be kept in the outer carton.
The active substance is triamcinolone acetonide 40 mg/ml.
The other ingredients are; benzyl alcohol, polysorbate 80, carmellose sodium, sodium chloride and water.
Kenalog IA/IM Injection belongs to a group of medicines called steroids. Their full name is corticosteroids. These corticosteroids occur naturally in the body, and help to maintain health and well-being. Boosting your body with extra corticosteroid (such as Kenalog IA/IM Injection) is an effective way to treat various illnesses involving inflammation in the body. Kenalog IA/IM Injection reduces this inflammation, which could otherwise go on making your condition worse. You must take this medicine regularly to get maximum benefit from it.
Kenalog IA/IM injection is a sterile aqueous suspension for injection and is supplied in 1.0 ml glass vials.
Marketing Authorisation Holder
Manufacturer
This leaflet was revised in September 2023
Bristol-Myers Squibb, ARC Uxbridge, Sanderson Road, New Denham, Denham, Buckinghamshire, UB8 1DH, UK
https://www.bmsmedinfo.co.uk/
+44 (0)1895 523 000
+44 (0) 800 731 1736